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ABSTRACT

THE ASSOCIATION OF PRESCRIPTION OPIOID EXPOSURE AND
PATIENT FACTORS WITH PROLONGED POSTOPERATIVE OPIOID USE IN
OPIOID NAÏVE PATIENTS

By
Jennifer Lanzillotta
August 2018

Dissertation supervised by Melissa Kalarchian, PhD
Background
Research suggests prolonged postoperative opioid use occurs in 4-13% of opioid naïve
patients and is related to factors other than surgical pain. However, it is unclear which
patient factors and prescribing practices are associated with prolonged use after surgery
among opioid naïve patients.
Objectives
To identify factors associated with prolonged postoperative opioid use (refills 90-180
days after surgery) in opioid naïve patients in two domains: specific patient
characteristics (demographics, smoking status, comorbidities, etc.) and exposure through
postoperative opioid prescriptions (in oral morphine milligram equivalents [OME]).
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Methods
An electronic medical record dataset analysis of inpatient and outpatient opioid naïve
adult orthopedic surgery patients at the University of Cincinnati Medical Center from
January 1, 2012 through December 31, 2017 was conducted. Opioid naïve was defined as
no opioid prescription filled in the past twelve months or only a perioperative
prescription filled 30 days or less prior to surgery. Patients were excluded if they had a
diagnosis of cancer or if they underwent a second surgery within 180 days of the first. A
multivariate logistic regression model was used to evaluate the relationship of each
domain to opioid refills 90-180 days after surgery.
Results
Of the 7,323 patients met inclusion criteria, 4% continued to refill opioid prescriptions
more than 90 days after their surgical procedure. Independent predictors of prolonged
postoperative opioid use were alcoholism (O.R. 2.0, C.I. 1.5-2.6), OME > 675 (O.R. 2.3,
C.I. 1.5-3.4), female gender (O.R. 1.7, C.I. 1.3-2.1), black race (O.R. 1.6, C.I. 1.2-2.2),
Medicaid insurance (O.R. 1.8, C.I. 1.3-2.5), and the following co-morbidities: diabetes
(O.R.1.5, C.I. 1.1-2.0), mood disorders (O.R. 1.4, C.I. 1.1-1.9), hypertension (O.R. 1.4,
C.I. 1.1-1.9), and chronic kidney disease (O.R. 1.6, C.I. 1.1-2.4).
Conclusions
Both opioid exposure and patient characteristics increase risk for prolonged opioid use
following orthopedic surgery. Since the risk of overdose increases with increased OME,
patients with high OME prescriptions should also receive a prescription for naloxone.
This study sheds light on the need for postoperative prescribing guidelines for clinicians.
To decrease the rate of prolonged postoperative opioid use, clinical changes can be
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investigated and implemented including collaborative perioperative pain management
strategies utilizing non-opioid pain control methods; perioperative patient screening;
education of patients and clinicians; and close postoperative follow-up, especially for the
most vulnerable populations.
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1.0 Dissertation Proposal
THE TEMPORAL ASSOCIATION OF
PATIENT CHARACTERISTICS AND PRESCRIBING PRACTICES
WITH PROLONGED POSTOPERATIVE OPIOID USE

1.1 Specific Aims
The opioid crisis in the United States has reached epidemic proportions. Opioid overdose
deaths nearly tripled in the fifteen years between 1999 and 2014 (Rudd, Aleshire, Zibbell, &
Gladden, 2016). The rate of drug overdose deaths increased significantly in both males and
females and among all adult age groups (Rudd, Akeshire, Zibbell, & Gladden, 2017). There were
52,404 drug overdose deaths in 2015, up from 47,055 in 2014. Of these deaths, 63% (33,091)
were attributed to opioids, the highest rate ever recorded. Ohio, the site of the proposed research,
is ranked the fourth highest state in opioid overdose deaths (Rudd et al., 2017).
There are many pathways to opioid misuse. Prescribing practices for managing postsurgical pain are important in the development of opioid misuse and the conversion of acute pain
to chronic pain (Kehlet, Jensen, & Woolf, 2006). Research suggests that prolonged postoperative
opioid abuse is a common complication of elective surgery (Brummett et al., 2017). In fact,
when opioid naïve patients (patients who have not taken an opioid for the past 12 months) are
prescribed an opioid post-surgery, 6-13% are still taking the medication three months later
(Brummett et al., 2017; Carroll et al., 2012; Johnson et al., 2016a; Sun, Darnall, Baker, &
Mackey, 2016). The overarching objective of this proposal is to identify risk factors for
prolonged opioid use post-surgery, which will directly inform efforts to prevent opioid use
disorder (OUD).
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Surgery places patients at risk for long term opioid use through exposure to narcotics
(Brummett et al., 2017; Carroll et al., 2012; Johnson et al., 2016; Sun et al., 2016). However,
research has been inconsistent as to which patient factors and prescribing practices are predictive
of prolonged postoperative use (Carroll et al., 2012; Rozet et al., 2014; Sun et al., 2016). The
proposed retrospective electronic medical record (EMR) chart review study of orthopedic
surgery patients (n=422) aims to utilize the Availability-Proneness Theory of Illicit Drug Abuse
framework to identify potential predictive factors of postoperative opioid use in the domains of
exposure and patient factors (Smart, 1980). The data will be extracted from the EMR through an
honest broker; data will be provided in a secure and HIPPA-compliant format.
Specific Aims are as follows:
Aim 1
Determine if postoperative opioid exposure is related to prolonged postoperative opioid
use. Exposure will be based on the initial post-surgery prescription as documented in the EMR,
including the medication, milligrams per pill, number of days, and number of pills prescribed.
Hypothesis 1. Exposure (converted to morphine milligram equivalents [MME] per
kilogram of body weight and length of prescription in days) will be associated with
continued use (prescriptions refills at 30-, 60-, and 90-days post-surgery).
Aim 2
Determine if individual patient factors are related to prolonged postoperative opioid use.
Patient factors will include demographics; smoking status; physical and psychological diagnoses
via International Classification of Diseases, 9th Revision (ICD-10) codes; pre-surgery
medications and history of opioid use; and the American Society of Anesthesiologists (ASA)
physical status classification.
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Hypothesis 2. Patient factors (e.g., history of opioid use, smoking status, psychological
conditions, and increased number of comorbid conditions) will be associated with
continued use (prescription refills at 30-, 60-, and 90-days post-surgery).
Exploratory Aim
Evaluate the relative contributions of exposure and patient factors in a multiple logistic
regression model predicting opioid refills at 90-days.
This study directly addresses National Institute of Drug Abuse (NIDA) funding priority
areas: NIDA Goal #2 is to “develop new and improved strategies to prevent drug use and its
consequences” (2016-2020 NIDA Stragetic Plan Advancing Addiction Science, 2016). By
“determining the mechanisms that underlie drug abuse and its consequences” this research
meets NIDA objective 2.1. Findings will be used to develop screening tools to identify patients
at high risk for opioid misuse, develop pain management protocols and prescribing guidelines,
increase the use of multi-modal anesthetics targeting different pain pathways, increase regional
anesthetic techniques, and develop educational strategies for patients, clinicians, and
stakeholders, thus meeting other NIDA objectives. It will support the development of evidenced
based best practices for pain management, and will help the nurse scientist applicant launch an
independent program of funded research in this high priority area.
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Background and Significance
National Opioid Epidemic
It is widely recognized that the United States is experiencing an opioid epidemic. There
has been an urgent call to action at the national level by the U.S. Congress, the Centers for
Disease Control and Prevention (CDC), the Department of Health and Human Services
(Addressing Prescription Drug Abuse in the United States, 2013), the U.S. Department of Justice
Drug Enforcement Agency (2016 National Drug Threat Assessment Summary, 2016), and the
National Institutes of Health (2016-2020 NIDA Stragetic Plan Advancing Addiction Science,
2016). Overdose deaths are increasing in males and females among all age groups; in 2015, 63%,
or 33,091 overdose deaths, were attributed to opioids, the highest rate ever recorded (Rudd et al.,
2017). Ohio, the state where the proposed retrospective EMR chart review will be conducted, is
ranked 4th in the nation in opioid overdose deaths (Rudd et al., 2017). There were 3,050 overdose
deaths in Ohio in 2015, up from 2,531 in 2014, a 21% increase (2015 Ohio Drug Overdose Data:
General Findings, 2015). Ohio ranked first in increased number of emergency department visits
related to opioid misuse between 2009 and 2014 and there was a 52% increase in the number of
inpatient admissions related to opioid misuse during that same time period (Weiss et al., 2017).
In addition to the human toll, the economic burden of the opioid epidemic is staggering.
The CDC’s estimated direct costs to insurers in 2011 for nonmedical use of prescription drugs
was over $72 billion per year ("Prescription Painkiller Overdoses in the U.S.," 2011). Although
men continue to misuse opioids more than women, this gap is narrowing ("Prescription
Painkiller Overdoses," 2013). The CDC reported a 400% increase in the use among women since
1999 compared to a 265% increase among men; the female age groups most affected are women
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of childbearing age ("Prescription Painkiller Overdoses," 2013). Thus, a better understanding of
risk factors could have a major public health impact.
Postsurgical Pain Management Contributes to the Opioid Epidemic
Prescription opioid abuse is contributing to the heroin epidemic: people often turn to
heroin when they are unable to obtain pain pills (Compton, Jones, & Baldwin, 2016). In fact, the
strongest predictor of heroin use disorder is previous prescription opioid dependence or opioid
use disorder; those who misuse opioids are 40 times more likely to become dependent on heroin
("New research reveals the trends and risk factors behind America’s growing heroin epidemic,"
2016).
Prescribing practices are an important component in preventing drug substance use
disorder ("New research reveals the trends and risk factors behind America’s growing heroin
epidemic," 2016). In fact, a surgical procedure was the precipitating pain event in 10-50% of
chronic pain patients depending upon the procedure (Kehlet et al., 2006). Brummet et al. (2017)
found that 6% of patients continued to fill opioid prescriptions whether the surgery was major or
minor, suggesting factors other than chronic pain contribute to long term use; Johnson et al.
(2016) found 13% of patients continue to fill opioid prescriptions more than 3 months after
surgery. Eliminating opioids entirely is not feasible, as this would prevent patients in severe pain
from obtaining relief. Therefore, clinicians need to strategically manage acute surgical pain in
order to minimize long-term opioid misuse and abuse.
Post-surgery Prescribing Practices may Place Patients at Risk for Prolonged Opioid Use
Surgical exposure to opioids places patients at risk for prolonged use. Previous literature
has commonly operationalized ninety days as significant long-term opioid use post-surgery,
referred to in this application as “prolonged use” (Manchikanti et al., 2012). Three studies
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showed that a surgical procedure places opioid naïve patients at risk for chronic opioid use.
Johnson et al. (2016) found that 13% of opioid naïve patients continued to fill prescriptions 90
days post-surgery. Carroll et al. (2012) found that 5% of opioid naïve patients continued to use
opioids greater than 150 days after a surgical procedure. Sun et al. (2016) found that seven of the
eleven surgical procedures examined placed opioid naïve patients at increased risk for chronic
opioid use.
Studies indicate that opioids are overprescribed after surgery and that there is wide
variation in prescribing practice. Recent studies indicate opioids are overprescribed after surgery.
In a survey of patients, less than 40% of urology patients used all of their opioid pain medication
after surgery; only 58% of the prescribed medication was used (Bates, Laciak, Southwick, &
Bishoff, 2011). In another survey of patients, less than one third of the prescribed opioid pain
medication was used by patients after their elective upper extremity surgical procedure (Rodgers,
Cunningham, Fitzgerald, & Finnerty, 2012). A prospective observational study examined
patients undergoing dermatology surgery. Only 11% of the patients used all of the prescribed
opioids (Harris et al., 2013). Overall, less than 40% of the prescribed pain medication was used.
The authors also reported wide variation in opioid prescribing practices among the physicians in
this study. In a retrospective chart review, wide variation in prescriber practices occurred not
only nationally, but within the same healthcare facility (Harris et al., 2014). These findings
indicate inconsistency in postoperative pain management practices, overprescribing of opioids,
and prolonged use after surgery that may be related to factors other than pain.
Individual Patient Characteristics Also Confer Risk
Certain patient characteristics may be predictive of postoperative opioid use, but these are
inconsistently reported across studies. Demographics such as gender, age, and socioeconomics

6

were particularly inconsistent. For instance, in one large analysis, the patient demographics
predicting prolonged postoperative opioid use were age less than 65, female gender, household
income under $60,000 per year, and private insurance (Johnson et al., 2016). Conversely, in
another large database analysis, men and patients over 50 years of age had higher rates of
prolonged use (Sun et al., 2016). Another study found no difference in opioid use six months
after surgery by age, gender, ethnicity, or type of surgery (Goesling et al., 2016). Rates also
varied by geographic location. Statistically significant higher rates of prolonged opioid use were
found in the U.S. Census Bureau West South Central (7.02%) and East South Central (7.85%)
regions compared to the Middle Atlantic Region (3.78%) (Brummett et al., 2017).
Researchers consistently found that patients who are already on opioids,
benzodiazepines, or addicted to alcohol are at increased risk of prolonged postoperative use
(Brummett et al., 2017; Goesling et al., 2016; Johnson et al., 2016; Rozet et al., 2014; Sun
et al., 2016; Waljee et al., 2016). In fact, mental health disorders, tobacco and alcohol abuse,
multiple comorbid conditions, and pre-existing pain conditions were independent predictors of
prolonged postoperative opioid use across all surgical procedures (Brummett et al., 2017;
Johnson et al., 2016). Preoperative opioid prescriptions, depressive symptoms, and selfperceived risk of addiction predicted prolonged postoperative use more than postoperative
intensity and duration of pain (Carroll et al., 2012). One study found that a preoperative
opioid prescription greater than 60 morphine milligram equivalents per day was associated with
prolonged use after surgery (Goesling et al., 2016). Additionally, patients already on opioids
preoperatively were often overprescribed opioids postoperatively (Waljee et al., 2016). Lastly,
post-traumatic stress disorder (PTSD) and preoperative opioid use were factors leading to
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chronic postoperative opioid use in young veterans having minor elective surgeries (Rozet et al.,
2014).
In summary, current evidence suggests that prolonged postoperative opioid use is related
to factors other than the duration and severity of surgical pain. Patients already using opioids,
benzodiazepines, tobacco, or abusing alcohol were at higher risk for prolonged postoperative
opioid use (Brummett et al., 2017; Goesling et al., 2016; Johnson et al., 2016; Rozet et al.,
2014; Sun et al., 2016; Waljee et al., 2016). Mental health disorders such as anxiety and
depression, a self-perceived risk of addiction, and multiple comorbid conditions independently
predicted prolonged use (Brummett et al., 2017; Carroll et al., 2012; Johnson et al., 2016). The
contribution of patient demographics is conflicting across studies.
The American Society of Anesthesiologists (ASA) physical status classification system was
developed to provide a uniform method for statistical analysis, for communication among
colleagues, and for other record keeping purposes. This system classifies patients according to
disease morbidity. (Johnson et al., 2016). The system, universally utilized by all anesthesia
providers for each surgical procedure, could ultimately assist providers in selecting multi-modal
pain management strategies for high risk populations and help guide postoperative acute pain
control methods. This system is summarized in Appendix 1.
ASA status was reported in two studies: a retrospective chart review of knee arthroscopies in
veterans and a prospective cohort study on the effect of preoperative opioid use in spine
surgeries (Armaghani et al., 2014; Rozet et al., 2014). Although neither of the two studies
indicated a statistically significant difference in postoperative opioid use related to ASA status,
certain studies have shown an increase related to increasing comorbidities.
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Proposed Retrospective EMR Chart Review Study
These early studies have begun to lay a foundation of knowledge for future research, but
significant gaps remain. The literature does not consistently identify which patients are at risk for
prolonged postoperative opioid use, or how prescribing practices influence prolonged
postoperative opioid use (Clarke, Soneji, Ko, Yun, & Wijeysundera, 2014). Examining opioid
use 30 days after surgery is also important because this indicates a high probability of continued
long term use at 90 days (Shah, Hayes, & Marting, 2017). Determining how (1) postoperative
opioid exposure (measured in morphine milligram equivalents [MME] per kilogram of body
weight and length of prescription in days) is related to prolonged postoperative opioid use at 30,
60, and 90 days and (2) determining individual patient factors related to prolonged opioid use,
including preoperative drug use, the patient’s physical and psychological medical conditions,
ASA status, and demographics, will address the gap in knowledge. The MME conversion table
is presented in Appendix 2.
The proposed retrospective EMR chart review study will extend previous work in several
ways. Current research has mainly focused on patients over age 64 with private insurance
(Johnson et al., 2016; Rozet et al., 2014; Sun et al., 2016; Waljee et al., 2016). This research will
not exclude adult patients based on age nor type of insurance or lack thereof. Both exposure and
patient factors will be examined in tandem. By evaluating the relative contributions of exposure
and patient factors, it is anticipated that we can account for some of the variability in prolonged
use. Previous literature has commonly described ninety days as significant prolonged use postsurgery (Manchikanti et al., 2012). Recent findings indicate that the risk of prolonged opioid use
increases after the first five days of therapy and again after 30 days of therapy regardless of the
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reason for the prescription (Shah, Hayes, & Martin, 2017). Because of this evidence, opioid use
at 30, 60, and 90 days postoperatively will be analyzed.
Surgery places patients at risk for prolonged opioid use, but the contributions of
prescribing practices and patient risk factors is unclear. Findings from the proposed study will be
used to develop evidenced based best practices for pain management, including screening tools,
perioperative pain management protocols and prescribing guidelines, increased use of multimodal anesthetics targeting different pain pathways and regional anesthetic techniques, and
educational strategies for patients, clinicians, and stakeholders.
Theoretical Framework for the Proposed Dissertation Study
The design of this dissertation research is based on The Availability-Proneness Theory of
Illicit Drug Abuse (Smart, 1980). This theory can be tested empirically; support for this theory
can be found in recent literature examining factors contributing to drug abuse (Ayllón &
Ferreira-Batista, 2017; Barrett, Joe, & Simpson, 1990; Rigg & DeCamp, 2014; Rigg & Murphy,
2013; Zeinali & Vahdat, 2011). This theory remains timely: it is currently utilized to explain
opioid dependence following exposure via prescriptions and was used to develop the Addiction
Susceptibility Questionnaire to measure a person’s likely predilection to drug abuse (Rigg &
DeCamp, 2014; Rigg & Murphy, 2013; Zeinali & Vahdat, 2011).
Basic tenets of this theoretical framework include that drug abuse occurs when two
factors are met: (1) the ease of access to drugs for an individual (exposure) and (2) the individual
patient factors contributing to the likelihood of abuse (proneness) (Smart, 1980). Thus, the theory
can be used to explain OUD in different populations, whether inner city, medical professionals
with high access to opioids, or post-surgical patient populations. Proneness to drug abuse is a
psychological construct. It describes a person’s innate tendency to seek out and use drugs. Those
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with low proneness will not seek out drugs, but may become dependent if there is a high
availability, such as a postoperative prescription or if they live in an environment where illicit
drugs are commonly available. Persons with certain predictive characteristics--proneness--will
seek drugs out, even when availability is low.
Persons who otherwise would not experience opioid exposure do so postoperatively.
Thus, this theory can be used to explain why some studies indicate a greater proportion of our
opioid-naïve patients who convert to opioid misuse after surgery (exposure) do not fit our
paradigm of drug abusers: they are young, female, and covered by private insurance (Johnson et
al., 2016). It also may explain why the gap between males and females is closing, and why
females of child-bearing age are greatly affected (Addressing Prescription Drug Abuse in the
United States, 2013). The second prong of this theory associates individual patient factors with
risk of SUD. If we identify predictors of abuse, we can identify high risk patients and intervene
more readily to prevent subsequent SUD.
This dissertation research seeks to identify potential predictive factors of postoperative
opioid use in these two domains through a retrospective EMR chart review. The theoretical
framework as it applies to this research proposal is shown in Figure 1. Proneness is represented
by patient factors (Table 1). We will examine patients undergoing orthopedic surgery and their
subsequent initial exposure to opioids. According to our hypotheses, patient factors and initial
exposure will be associated with subsequent prescription refills. We will measure prescription
refills at 30, 60, and 90 days as described to determine prolonged use, which could lead to OUD.
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Hx of opioid
use/preoperative
exposure to opioids
Smoking
Demographics
ASA Status
Psychological
conditions
Physical comorbidites

EXPOSURE
:
Perioperative
Opioid
Prescription
(MME)

(30, 60, 90 days
post-surgery)

SUBSTANCE USE DISORDER
Moderate
Severe

Prolonged
postoperative
opioid use
More than 90
days postsurgery

Opioid Use
Disorder
(Addiction)

Orthopedic
surgery
Theoretical Framework (Adapted from The Availability Proneness Theory of Illicit Drug Abuse Model by Smart, 1980.)

Pathophysiology of Drug Abuse
The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) describes SUD with
four major categories: impaired control, social impairment, risky use, and pharmacological
criteria such as tolerance and withdrawal. It can be classified as mild, moderate, or severe. Not
all persons exposed to opioids will progress down the SUD continuum. The most severe form of
SUD is estimated to affect 10% of the population (Volkow, Koob, & McLellan, 2016). Although
addiction is not defined by the American Psychiatric Association, the term is still commonly
used and represents the end of the SUD continuum; addiction can be considered the severe form
of SUD (Volkow et al., 2016).
The disease model of addiction describes OUD similarly to other chronic health
conditions such as diabetes and heart disease: it the result of a combination of genetic,
behavioral, environmental, and biological factors. Changes in brain neurobiology in response to
drug use include up and down regulation of neuronal receptors and neurotransmitter changes.
This results in impaired dopamine release, conditioned responses, and re-setting of the brainreward system, thus altering motivation and behavior (Volkow et al., 2016). Once the person has
progressed to severe SUD, craving overrides behavioral control despite negative consequences.
The disease is characterized by relapse and can be progressive, leading to disability and
premature death. This definition is accepted by the American Medical Association and the
American Society of Addiction Medicine (ASAM) ("Definition of Addiction," 2017).
Fit with National Priorities
The National Institute on Drug Abuse (NIDA), in response to this epidemic, released its
strategic plan for 2016-2020 with goals and objectives to stem the tide. Goal #2 is to “Develop
new and improved strategies to prevent drug abuse and its consequences.” One objective of the
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goal is to determine the mechanisms that underlie individual risk and resilience for addiction and
common comorbidities, which is a fit with the proposed retrospective EMR chart review
dissertation study by a nurse scientist (2016 National Drug Threat Assessment Summary, 2016).
Innovation
This innovative dissertation research will provide new insight into developing strategies
to combat the national opioid epidemic by using a theoretically grounded approach to studying
the effect of prescribing practice (exposure) and the predictors of SUD (proneness) together.
The innovation of this research lies in the ability to examine both prescribing practices and
patient characteristics for comparison and analysis of their relative contributions to prolonged
opioid use.
As mentioned earlier, previous studies have not examined the impact of prescribing
practices in conjunction with predictors of prolonged postoperative opioid use (Clarke et al.,
2014). For example, Johnson et al. (2016) examined the predictors of prolonged opioid use in
opioid naïve patients after common hand surgeries, but did not examine the medications
prescribed, medication dosages, or number of pills dispensed. Sun et al. (2016) concluded that
opioid naïve patients are put at risk for long-term opioid use after surgery, but the research did
not examine the provider prescribing practices that may have influenced the outcomes. In a
review by Manchikanti and colleagues (2012), the authors conclude that the greatest contributors
to the current opioid epidemic are prescribing patterns based on misinformation, lack of
education, the perceived safety of opioids, lack of willingness of patients to use other pain
control modalities, and health system barriers. Thus, research to date has tended to focus on
either prescribing or exposure, but has not considered both together.
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In short, this project will move science forward by examining the post-surgical provider
prescribing practices (exposure) and the predictors of prolonged use (proneness) in tandem. This
will, in turn, lead to identification of patients at high risk for postoperative opioid misuse,
development of pain management protocols and prescribing guidelines, increase in the use of
multi-modal anesthetics targeting different pain pathways, and the development of educational
strategies for patients, clinicians, and stakeholders, ultimately decreasing postoperative opioid
misuse, a national crisis.
Research Design and Methods
Overview and Research Design
We propose a retrospective EMR chart review to (1) examine the temporal association of
postoperative opioid exposure (measured in MME per kilogram of body weight and length of
prescription in days) to prolonged opioid use at 30, 60, and 90 days post-surgery and (2)
determine individual patient factors related to prolonged opioid use, including history of opioid
use, demographics, smoking status, and certain physical and psychological conditions.
Setting
The EMR chart review will be conducted at University of Cincinnati Medical Center
(UCMC), a large, urban teaching hospital that is part of an academic medical center. This site
treats Medicare, Medicaid, private insurance, self-pay, and the uninsured. The data will be
extracted by Biomedical Informatics, the institutional Honest Broker for UC Health. The data
will be provided in a secure, HIPPA-compliant format ensuring patient confidentiality and
protection will be maintained. There are five Epic-trained database analysts on the team and
supporting faculty with broad informatics experience that will lend their expertise during this
retrospective EMR chart review. Biomedical Informatics has provided a letter of support
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confirming that they will provide the required data in a compliant and secure format along with
supporting personnel. The UCMC Chief Nursing Officer and Vice President of Patient Care
Services has also provided a letter of support confirming access to the Epic EMR for this
research study.
Sample
The sample for this research will consist of orthopedic surgery patients who underwent
surgery at UCMC. This class of surgery was selected because research of privately insured, 18 to
64-year-old patients, showed orthopedic surgeries to be the highest risk for prolonged
postoperative opioid use and that preoperative opioid use is highest in orthopedic patients (Sun et
al., 2016; Wilson et al., 2015). Inclusion criteria are (1) over age 18, (2) having had orthopedic
surgery, and (3) received a perioperative opioid prescription in the time frame of 30 days prior to
surgery through postoperative discharge. The exclusion criterion is patients without a current or
previous diagnosis of cancer according to the ICD medical codes because cancer pain treatment
is vastly different from acute pain treatment. Both opioid naïve patients and patients using
opioids preoperatively will be included. For this research, opioid naïve is defined as patients who
have not filled an opioid prescription in the past twelve months or who only filled a perioperative
prescription; perioperative prescriptions are defined as thirty days or less prior to surgery so that
patients have their pain medication available at home immediately following discharge.
Data Collection
Data will be extracted from the Epic EMR by an honest broker. Prescriptions for opioids
will be extracted from the EMR. Data collected will include the medication prescribed; the
number of pills and days prescribed; and the milligrams per pill. MME dosages will be
calculated for comparison among different opioids. This method is often used in the literature for
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comparison among opioids and is also used by clinicians. The patient’s body mass index (BMI)
(kg/m2) will be calculated based on height and weight as documented in the medical record.
Table 1 summarizes the data to be extracted from the EMR.
Table 1
Data to be Collected and Coded from the Electronic Medical Record
Patient Factors

Person undergoes
surgery

Variable
Demographics

Data to be extracted
Age
Gender
Race

Ethnicity

Coding
Months, years
Male (yes/no)
White or Caucasian
Black or African American
Asian
American Indian and Alaskan Native
Hispanic (yes/no)

Weight status

Height and Weight

BMI (Kg/m2)

Smoking status

Smoker

Yes/no

Physical status

ASA Category

Status (I, II, III, IV, E)

Type of insurance

Insurance at time of
surgery

Private Insurance
Medicaid
Medicare
No insurance or self-pay

Medical Conditions

ICD Codes

Diabetes
Chronic obstructive pulmonary disease
Emphysema
Coronary artery disease
Hypertension
Obesity
Mood disorders
Chronic pain
Cerebrovascular disease
Chronic Kidney disease
Liver disease
Alcoholism
Drug abuse

Preoperative
Prescriptions

Type of medication

Antidepressants

Type of Surgery

Specific orthopedic
procedure

Antipsychotics
Antianxiety
Opioid *
Non-opioid pain medication
Other
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Total knee arthroplasty
Total hip arthroplasty
Spine surgery

Shoulder surgery
Upper extremity surgery (non-joint
replacement)
Lower extremity surgery (non-joint
replacement)
Other

Exposure

Perioperative &
Postoperative Opioid
Prescriptions

Trauma

Yes/No

Number of pills,
number of days, mg per
pill
Date of prescription

Morphine milligram equivalents (if
applicable)

Refill

Yes/no *

> 30 days pre-surgery
< 30 days pre-surgery
At time of surgery *
30-59 days post-surgery
60-89 days post-surgery
90-180 days post-surgery *

* Primary outcome = Prolonged opioid use defined as opioid prescription refills 90-180 days
post-surgery (categorical)
Power and Sample Size
Based on power of .80, .05 for alpha, an odds ratio of 1.5, with the proportion of people
at 13% (Pr(Y=1|X=1) and a two-tailed test, a sample size of 422 is needed (Faul, Erdfelder,
Buchner, & Lang, 2009; Johnson et al., 2016). Due to the change in opioid prescribing practices
over time, orthopedic surgery patients from 2012 forward will be considered (Wunsch,
Wijeysundera, Passarella, & Neuman, 2016). As the cost of analyzing more EMRs does not
increase with a greater sample size, we will collect data on the maximal number of patients
available in the specified time period.
Data Analysis
Data analysis will be completed by the PhD student PI working with a data analyst under the
supervision of a statistician. Following data extraction by an honest broker from the EMR, a
research assistant will help with data cleaning and creation of a data dictionary. Completeness of
records will not be known until data pulled and will be addressed with statistician. We will begin
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by examining the primary outcome variable to see how many patients have refilled a prescription
at 90 days (primary outcome; binary). We will also calculate variables such as MME.
Descriptive analyses will be run for means and standard deviations for continuous predictor
variables, and frequency and ranges of scores will be examined for categorical variables, to
identify any outliers. For continuous variables that are non-normally distributed (e.g. number of
days from the initial opioid prescription), we will examine the distribution to create categories
(e.g. more or less than one week). Any three-category variables will be dummy coded in
preparation for modelling. Reference groups will be labelled as zero.
Following the descriptive analysis and recoding, Chi-squared analysis will be run based
on use at 90-days post-surgery and each categorical variable individually. We will run cross-tabs
to make sure we have sufficient number of observations at each crosstab (5 or more in each cell).
All variables that are statistically significantly related to the 90-day outcome will be considered
for the modelling. Before beginning the modeling, tests for multicollinearity, influential cases,
and linearity of logit will be conducted to verify that all assumptions of the logistical regression
model are met.
A logistic regression model will be used to evaluate study hypotheses and identify factors
that predict prolonged opioid use. The categorical variable of refill at 90 days will be entered as
the dependent outcome variable, and the variables that were identified from the individual Chi
square analyses as the independent predictor variables. The Wald statistic will be used to
determine the contribution of each predictor to the model. The beta weight will be used to
evaluate the strength and direction of the association. Cox and Snell pseudo R squared will be
used to determine the explanatory power of the model in relation to the variance in the dependent
variable that is due to the independent variable. The odds ratio for each of the predictors will
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allow us to determine how many times that predictor increases the odds of refilling a prescription
at 90 days. A p-value < .05 will be used as the criterion for determining significance.
Study Hypotheses will be Evaluated as Follows
Hypothesis 1. Exposure (converted to morphine milligram equivalents [MME] per
kilogram of body weight and length of prescription in days) will be significantly associated with
continued use (prescriptions refills at 30-, 60-, and 90-days post-surgery). The predictor variable
will be MME and the outcome variable will be refills at 90 days.
Hypothesis 2. Patient factors (e.g., history of opioid use, smoking status, psychological
conditions, and increased number of comorbid conditions) will be significantly associated with
continued use (prescription refills at 30-, 60-, and 90-days). A hierarchical variable model where
the variables observed to be related to the outcome will be entered based on their theoretical
importance (forward entry). In addition, Chi-square change in fit of each successive model will
be examined to determine significance of the added predictor variable.
Exploratory aim. We will evaluate the relative contributions of exposure and patient
factors in a multiple logistic regression model predicting opioid use at 90-days. A logistic
regression analysis will be run with prolonged opioid use as the dependent variable and the
variables that were retained in the evaluation of hypotheses 1 and 2 as the independent variables,
using an approach similar to that outlined above to explore the relative contributions of exposure
and patient characteristics.
Limitations
This dissertation study has several limitations: (1) this research will examine orthopedic
patients so the results may not be generalizable to all surgery patients, (2) this study may not
reflect the population of the nation as a whole, and (3) patients may seek opioids from outside
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sources that will not be captured in the EMR. It is also possible that there will not be sufficient
variability in prescribing practices or the outcome variable to conduct the modeling and detect
the anticipated effects, and if we encounter this pitfall, the descriptive findings will inform and
guide future work.
Future Directions
The proposed study is the first step in a research career in a high priority area. Results will
be published in peer-reviewed journals, presented at interprofessional conferences, and used to
support future grant applications. Ultimately, this body of research will lead to the development
of pain management protocols and postoperative prescribing guidelines, increased use of multimodal anesthetics targeting different pain pathways, increased regional anesthetic techniques,
and the development educational strategies for patients, clinicians, and stakeholders.
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Appendix A
American Society of Anesthesiologist Physical Status Classification
Status
ASA I

Definition
Normal, healthy patient

Examples (not an exhaustive list)

ASA II

A patient with mild systemic
disease

Smoker, mild alcohol use, pregnancy, 30< BMI<40, well
controlled diabetes and high blood pressure, mild lung
disease

ASA III

A patient with severe systemic
disease

Poorly controlled diabetes or high blood pressure, morbid
obesity (BMI >40), alcohol dependence, history of stroke,
myocardial infarction, coronary artery disease, pacemaker,
dialysis

ASA IV

A patient with severe systemic
disease that is a constant threat to
life

Symptomatic lung disease, symptomatic heart disease,
hepatorenal failure. Has at least one disease that is poorly
controlled (hypertension, diabetes)

ASA V

Patients not expected to survive
more than 24 hours without
surgery

Multi-organ system failure

ASA VI

A declared brain-dead patient

Organ procurement

From American Society of Anesthesiologists https://www.asahq.org/resources/clinicalinformation/asa-physical-status-classification-system. Retrieved May 2017.
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Appendix B
Morphine Milligram Equivalent Conversion Table
Opioid (doses in mg/day except where noted)

Conversion Factor

Codeine

0.15

Fentanyl transdermal (in mcg/hr)

2.4

Hydrocodone

1

Hydromorphone

4

Methadone

1-20 mg/day

4

21-40 mg/day

8

41-60 mg/day

10

≥ 61-80 mg/day

12

Oxycodone

1.5

Oxymorphone

3
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Appendix C
Protection of Human Subjects
The proposed dissertation study involves a retrospective chart review utilizing data from
the electronic medical record (EMR) at the University of Cincinnati Medical Center. Because the
data to be extracted from the EMR were not collected specifically for the proposed
dissertation study, and no one on the study team will have access to patients' identifying
information, the study is not considered human subjects research. Expedited Internal Review
Board (IRB) approval will be obtained. Because this dissertation research involves both the
University of Cincinnati and Duquesne University, IRB will be obtained from both institutions.
Initial approval will be sought from Duquesne. Once approved, an IRB/Independent Ethics
Committee Authorization Agreement form will be submitted to the University of Cincinnati IRB
for approval along with any other required documentation.
Following approval by the IRBs at Duquesne University, where the PI is a doctoral
student, as well as the University of Cincinnati, an honest broker from Biomedical Informatics
will extract and provide the data in a de-identified, HIPAA compliant, and secure format that
will not allow linkage to the patient. There are five Epic data based trained analysts on the team
along with supporting faculty with broad informatics experience to assist in procuring and
providing the data to the research team in this secure format. The de-identified dataset will be
stored on a password protected computer, and will only be accessible to members of the research
team.
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2.0 INTEGRATIVE REVIEW OF THE LITERATURE
Manuscript #1
THE IMPACT OF PATIENT CHARACTERISTICS AND POSTOPERATIVE OPIOID
EXPOSURE ON PROLONGED POSTOPERATIVE OPIOID USE—
AN INTEGRATIVE REVIEW
This chapter is a pre-print version of the article accepted for publication by Pain Management
Nursing.
2.1 Abstract
The United States is experiencing an opioid overdose crisis. Research suggests prolonged
postoperative opioid use, a common complication following surgery, is associated with opioid
misuse, which, in turn, is the greatest risk factor of heroin misuse.
Objectives: To evaluate how postoperative opioid exposure relates to prolonged use and to
identify factors that predict prolonged postoperative opioid use.
Design: An integrative review of the literature
Data Sources: Electronic and hand searching methods were used in PubMed, Embase, Cochrane
Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, CINAHL, and
SCOPUS. Search terms included opioid, opiate, postoperative pain, drug administration,
prescribing pattern, prescription, inappropriate prescribing, self-medication, patient-controlled
analgesia, opioid-naïve patients, and prolonged opioid use.
Review/Analysis Methods: Data was synthesized by identifying themes reflecting the results of
the review. A quality assessment of the articles was also conducted.
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Results: Fourteen articles were included and two main themes emerged: (1) Surgery places
opioid naïve patients at risk for prolonged opioid use and (2) Certain patient characteristics may
be predictive of prolonged postoperative opioid use.
Conclusions: Prolonged postoperative opioid use is related to factors in addition to prescribing
practices. Researchers consistently found that patients who are already on opioids,
benzodiazepines, or addicted to alcohol; who have mental health disorders, depressive
symptoms, or a self-perceived risk of addiction; and patients with multiple co-morbidities are at
greater risk of prolonged use; demographics were inconsistent.
Nursing Implications: Studies are needed to determine the predicting characteristics of
prolonged postoperative opioid use, the type of surgeries that place patients at most risk, and the
effect postoperative exposure to opioids has on prolonged use. This information can be used to
develop and implement protocols to prevent misuse among high-risk patients.
2.2 Background
The opioid crisis in the United States (U.S) has reached epidemic proportions
(Understanding the Epidemic, 2017). Opioid overdose deaths nearly tripled in the fifteen years
between 1999 and 2014 (Rudd, Seth, David, & Scholl, 2016). There were 52,404 drug overdose
deaths in 2015, up from 47,055 in 2014 (Rudd et al., 2016). Of these deaths, 63% (33,091) were
attributed to opioids, the highest rate ever recorded in a single year (Rudd et al., 2016).
Provisional data for 2017 indicates 64,070 people will die from unintentional drug overdoses, a
20% increase from the previous year (Provisional Counts of Drug Overdose Deaths, as of
8/6/2017, 2017).
The rate of drug overdose deaths is increasing significantly in both males and females
and among all adult age groups (Rudd, Akeshire, Zibbell, & Gladden, 2017). Although men
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continue to misuse opioids more than women, the gap is narrowing ("Prescription Painkiller
Overdoses," 2013). The Centers for Disease Control and Prevention (CDC) reported a 265%
increase among men compared to a 400% increase in use among women since 1999; the female
age groups most affected are women of childbearing age ("Prescription Painkiller Overdoses,"
2013). In addition to the human toll, the economic burden of the opioid epidemic is staggering.
The CDC’s estimated direct costs to insurers in 2011 for nonmedical use of prescription drugs
was over $72 billion per year ("Prescription Painkiller Overdoses in the U.S.," 2011).
In response to this epidemic, there has been an urgent call to action at the national level
by the U.S. Congress, the CDC, the Department of Health and Human Services (Addressing
Prescription Drug Abuse in the United States, 2013), the U.S. Department of Justice Drug
Enforcement Administration (DEA) (2016 National Drug Threat Assessment Summary, 2016),
and the National Institutes of Health (National Institute on Drug Abuse 2016-2020 Strategic
Plan, 2016). In fact, the DEA reports that opioids--such as prescription drugs, fentanyl, and
heroin--are the most significant drug threats facing our country (2016 National Drug Threat
Assessment Summary, 2016). The strongest predictor of heroin abuse is previous prescription
opioid misuse, and those who misuse opioids are forty times more likely to become dependent on
heroin; people often turn to heroin when they are unable to obtain opioid analgesics (Compton,
Jones, & Baldwin, 2016; Rudd et al., 2016).
Research suggests that prolonged postoperative opioid use is a common complication of
elective surgery (Brummett et al., 2017). Opioids are often overprescribed postoperatively for
post-surgical pain management, and research indicates that only 28% to 58% of the prescribed
pills are used by patients after elective procedures (Bates, Laciak, Southwick, & Bishoff, 2011;
Harris et al., 2014; Harris et al., 2013; Hill, McMahon, Stucke, & Barth, 2017; Kim et al., 2016;
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Rodgers, Cunningham, Fitzgerald, & Finnerty, 2012). Additionally, wide variation in prescriber
practices are found not only nationally, but also among surgeons practicing at the same facilities
(Harris et al., 2014; Hill et al., 2017). The average duration of opioid prescriptions has not
increased over time; however, the mean morphine equivalents prescribed to opioid naïve
patients, defined as no opioid prescription in the six months preceding surgery, showed increases
from 2004 to 2008 and again from 2008 to 2012 in a study examining four common surgical
procedures: carpal tunnel release, laparoscopic cholecystectomy, inguinal hernia repair, and knee
arthroscopy (Wunsch, Wijeysundera, Passarella, & Neuman, 2016).
A review article examining postoperative discharge opioid prescribing reported on three
studies and concluded that there is evidence of unintended prolonged postoperative opioid use
(Macintyre, Huxtable, Flint, & Dobbin, 2014). Prescribing practices and predictive patient
characteristics were not examined in this review. Current research includes findings regarding
prolonged postoperative opioid use, characteristics that may contribute to prolonged use, and
prescribing practices. However, no previous literature reviews were discovered evaluating
postoperative opioid exposure and the predictive patient characteristics of prolonged opioid use
after surgery.
Prescription opioid misuse is a complex and multifaceted problem. Contributors are
biological, psychological, social, and institutional (Addressing Prescription Drug Abuse in the
United States, 2013; "Definition of Addiction," 2018). Prolonged opioid use has been described
as continued use beyond the normal and expected time for healing, with 90 days being the cutoff
based on multiple definitions and regulations according to the American Society of
Interventional Pain Physicians Guidelines (Manchikanti et al., 2012). A better understanding of
patient factors and prescribing practices on prolonged postoperative opioid use may facilitate
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development of patient focused interventions including screening tools to identify high risk
patients, pain management protocols and prescribing guidelines, and educational strategies for
patients, clinicians, and stakeholders. Ultimately, this information may lead to implementation of
best practice guidelines for acute postoperative pain management.
2.2.1 Objectives
The purpose of this integrative review is to evaluate and synthesize current scientific
literature and evidence on how postoperative opioid exposure is related to prolonged use and to
identify potential predictive patient characteristics of prolonged postoperative opioid use in the
U.S. The following questions guided this review:
(1) Is postoperative exposure to opioids associated with prolonged use?
(2) Are there specific patient characteristics associated with prolonged postoperative
opioid use?
2.3 Methods
2.3.1 Design
An integrative review was conducted according to the methodology of Whittemore and
Knafl (2005). This type of review includes various types of evidence, both empirical and
theoretical, and may include randomized controlled trials, qualitative studies, observational
studies, clinical experts, and gray literature (Whittemore & Knafl, 2005). The components of this
method are problem identification, literature search, data evaluation, data analysis, and
presentation (Whittemore & Knafl, 2005, p. 549). The literature search was conducted with the
aid of health sciences librarians to ensure a thorough and complete search. This review was also
conducted in accordance with the latest Preferred Reporting Items for Systematic Reviews and
Meta-analysis (PRISMA) statement (Moher, Liberati, Tetzlaff, Altman, & PrismaGroup, 2009).
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2.3.2 Data Sources
The clinical databases included in the search process were PubMed, Embase, Cochrane
Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, and CINAHL.
In addition, ClinicalTrials.gov and abstracts from the Annual Meeting of the American Pain
Society were searched by title for relevancy of unpublished documents for this review; no
articles were added from either of these two sources. Scopus was also used to check relevant
article reference lists and citing articles. An ancestry search of the reference section of included
articles was conducted for completeness. Search strategies were developed by a team of
researchers based on the clinical question and key terms.
Two librarians added additional terms and appropriate subject headings depending on the
particular database searched (i.e. Medical Subject Headings (MeSH), the National Library of
Medicine controlled vocabulary; Emtree, the Embase database controlled vocabulary; and
CINAHL subject headings). The following key search terms were used in strategies specific to
each database and organization: opioid; opiate; postoperative pain; drug administration;
prescribing pattern; prescription; inappropriate prescribing; self-medication; patient-controlled
analgesia; opioid-naïve patients; and prolonged opioid use. See the specific search strategies in
Table 1.
Titles and abstracts were screened by the first and second authors to determine if the
articles met the subject of interest and the inclusion criteria. Articles were included if they were
published in original, peer-reviewed journals, written in English, from the U.S., and studies of
adult patients. No date restriction was imposed in any database except CINAHL (January 1,
2011). Notably, the review by Macintyre (2014) found no articles predating 2012 in their search.
Articles outside the U.S. were excluded due to different drug formularies and different laws
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regarding prescribing practices in other countries. Searches in all resources were done through
June 21, 2017 (See PRISMA Diagram Figure 1).
After applying the inclusion and exclusion criteria and removing duplicates, 683 titles
and abstracts were screened. Nineteen articles were initially selected for full text review. Seven
articles were excluded after the full text review: a study on guideline implementation at a single
center, a pilot study for an included study, an intervention for preoperative counseling, and four
that did not meet the inclusion criteria. The ancestry search of the twelve included articles
produced two more articles, and in total fourteen articles were included in this review. A
summary of the articles is presented in Table 2.
2.3.3 Review Methods
Data were synthesized by categorizing, summarizing, comparing, and interpreting findings
across all fourteen articles to identify themes that reflect the focus of the integrative review. Key
components included: author and publication year, purpose, design, sample/setting, statistical
analysis, findings, limitations, and recommendations for future research. A matrix of studies
reviewed is displayed in Table 2. A quality assessment was conducted on articles included in the
review using a scale adapted from other integrative reviews (Clark, Wilder, & Winstanley, 2014;
Jinks, Cotton, & Rylance, 2011). The results of the quality assessment are listed in Table 3. Six
articles did not describe attrition or the process for handling missing data. Three articles did not
adequately address ethical considerations, specifically whether Institutional Review Board
approval or consent was obtained.
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2.4 Results
2.4.1 Description of Studies
A total of fourteen articles were included in the final analysis. Five retrospective database
analyses were included (Brummett et al., 2017; Johnson et al., 2016; Sun, Darnall, Baker, &
Mackey, 2016; Waljee et al., 2016; Wunsch et al., 2016). The database analyses all consisted of
commercial insurance claims to examine factors of prolonged opioid use after certain surgeries.
These studies were limited to patients 18 to 64 years of age with private insurance; Medicare,
Medicaid, and patients without insurance were not examined. There were three prospective
observational studies, one of which was a pilot study (Carroll et al., 2012; Harris et al., 2013;
Kim et al., 2016). One single site study included both a retrospective chart review and a patient
survey (Hill et al., 2017). There were two single site retrospective chart reviews (Harris et al.,
2014; Rozet et al., 2014) and two studies based on patient surveys (Bates et al., 2011; Rodgers et
al., 2012). Lastly, there was one secondary analysis of data (Goesling et al., 2016). The matrix of
studies is displayed in Table 2.
Three of the five database analyses used the Truven Health MarketScan Commercial
Claims and Encounters data set. This is comprised of 100 U.S. health plans (Johnson et al., 2016;
Sun et al., 2016; Waljee et al., 2016). In one study, the records of 77,573 opioid naïve patients
(defined as no opioid prescription filled in the eleven months prior to surgery) who underwent
common elective hand surgeries (carpal tunnel release, carpometacarpal arthroplasty/arthrodesis,
cubital tunnel release, trigger finger release) and common hand surgeries for trauma (closed
distal radius fracture fixation, flexor tendon repair, metacarpal fracture fixation or phalangeal
fracture fixation) were examined to determine the risk of prolonged (greater than 90 days)
postoperative opioid use (Johnson et al., 2016). Another analysis examined the records of
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296,452 patients who underwent the following common hand surgeries to evaluate opioid use
due to procedure type and patient factors including preoperative opioid use: carpal tunnel release,
trigger finger release, cubital tunnel release or thumb carpometacarpal arthroplasty (Waljee et al.,
2016). A third analysis examined 641,941 opioid naïve surgical patients (defined as no opioid
prescription filled in the twelve months prior to surgery) undergoing eleven common surgeries
and 18,011,137 opioid naïve non-surgical patients for comparison to see which patients were at
highest risk for continued opioid use at one year (Sun et al., 2016).
The data for two of five database analyses were obtained from a managed care company
affiliated with OptumInsight© through the Clinformatics Data Mart© Database. One examined
155,297 opioid naïve patients (defined as no opioid prescription filled in the six months prior to
surgery) undergoing carpal tunnel release, laparoscopic cholecystectomy, inguinal hernia repair,
and knee arthroscopy in 2004, 2008, and 2012 to analyze the change in prescribing patterns over
time (Wunsch et al., 2016). The other examined 36,177 patients with private insurance
undergoing major and minor surgical procedures for comparison (Brummett et al., 2017).
There were three prospective observational studies included (Carroll et al., 2012; Harris
et al., 2014; Harris et al., 2013; Kim et al., 2016). One study enrolled 109 patients having total
hip replacement, total knee replacement, thoracotomy, mastectomy, or lumpectomy procedures
in a pilot study (Carroll et al., 2012). Preoperatively, psychological tests were administered and a
history of substance abuse performed to measure these determinants on prolonged postoperative
opioid use. Another study examined 212 adults undergoing dermatological surgery to determine
characteristics associated with opioid prescribing practices and postoperative opioid
consumption in this surgical population (Harris et al., 2013). The researchers then conducted a
retrospective chart review of 233 dermatological surgical patients along with a survey emailed to
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members of the American Society for Dermatological Surgery to increase understanding of
prescribing practices in this population (Harris et al., 2014). The third prospective study
examined 1,419 patients age 18 to 93 after outpatient procedures involving the hand, wrist,
forearm, or shoulder (Kim et al., 2016). Data was collected prospectively and a telephone
interview determined the number of opioid pills used after surgery.
Three studies used patient surveys to obtain data (Bates et al., 2011; Hill et al., 2017;
Rodgers et al., 2012). In one study, a sample of urology surgery patients was used to examine
prescribing practices, opioid consumption, and disposal of surplus medication (Bates et al.,
2011). Another examined 250 patients undergoing elective outpatient upper extremity surgeries
using a post-surgical phone interview to assess pain control and consumption of opioids
postoperatively (Rodgers et al., 2012). In the third study, researchers contacted opioid naïve
patients (defined by the researchers as no opioid use 30 days prior to surgery) undergoing five
common general surgery procedures (partial mastectomy, partial mastectomy with sentinel
lymph node biopsy, laparoscopic cholecystectomy, laparoscopic inguinal hernia repair, and open
inguinal hernia repair) to determine how many opioid pills were taken postoperatively (Hill et
al., 2017). Lastly, a retrospective chart review of 145 veterans undergoing knee arthroscopies to
identify risk factors for chronic postoperative pain, especially post-traumatic stress disorder
(PTSD) was completed (Rozet et al., 2014). This study reviewed medical and pharmacy records
of 18 to 50-year-old patients at a single site.
2.4.2 Synthesis of Studies
The purpose of this review was to synthesize current scientific literature and evidence on
how postoperative opioid exposure is related to prolonged use and to identify potential predictive
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characteristics of prolonged postoperative opioid use. Careful analysis and synthesis of these
articles resulted in the emergence of two major themes.
2.4.2.a. Surgery places patients at risk for prolonged opioid use.
Five studies suggest that surgery places opioid naïve patients at risk for prolonged
postoperative opioid use (Brummett et al., 2017; Carroll et al., 2012; Goesling et al., 2016;
Johnson et al., 2016; Sun et al., 2016). Prolonged use was defined as (1) filling an opioid
prescription 90 to 180 days after surgery (Brummett et al., 2017; Johnson et al., 2016), (2) filling
either more than 120 days’ supply of opioids or 10 or more refills 90 to 365 days after surgery
(Sun et al., 2016), or (3) filling a prescription more than180 days after surgery (Goesling et al.,
2016). In a study of patients undergoing major surgeries such as mastectomies, thoracotomies,
and total joint replacements, median time to opioid cessation post-surgery was calculated: 6% of
opioid naïve patients continued to use opioids more than 150 days after these procedures (Carroll
et al., 2012). Compared with the 0.136% baseline rate of opioid use measured in nonsurgical
reference groups, rates of opioid use more than 90 days after surgery were significantly greater
for all surgical procedures other than cesarean sections (Sun et al., 2016). In this study, patients
undergoing total knee replacements (TKA) had the highest rates of chronic opioid use (1.41%)
followed by two common surgeries: simple mastectomies and total hip replacements (THA)
(0.6%). Similarly, 6.5% of patients undergoing major surgeries such as colectomies, bariatric
surgeries, and hysterectomies and 5.9% of patients undergoing minor surgical procedures such as
thyroidectomies, parathyroidectomies, and laparoscopic cholecystectomies were still taking
opioids more than 90 days after their surgery (Brummett et al., 2017). There was no significant
difference between the two surgical groups in regard to prolonged postoperative opioid use.
There was a significant difference, however, when compared to the 0.4% rate of new persistent
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opioid use in the nonsurgical control group (Brummett et al., 2017). Patients undergoing TKA
and THA were surveyed at one, three, and six months post-surgery. At six months, 8.2% of TKA
and 4.3% of THA patients were still using opioids (Goesling et al., 2016). Lastly, in patients
undergoing common elective hand surgeries, 13% of opioid naïve patients continue to fill
prescriptions 90 days after their surgical procedure (Johnson et al., 2016).
Among these studies, evidence varies on how the type of surgery influences prolonged
postoperative opioid use. In a study of 11 procedures, research suggests total joint replacements,
mastectomies, and open and laparoscopic cholecystectomies and hernia repairs are more likely to
lead to prolonged postoperative opioid use than open and laparoscopic appendectomies,
functional endoscopic sinus surgeries, cataract surgeries, transurethral prostate resections, and
simple mastectomies (Sun et al., 2016). However, other findings suggest no significant
difference in prolonged opioid use between patients undergoing major and minor surgeries
(Brummett et al., 2017). In addition, no association was found between change in joint pain over
time and prolonged opioid use in patients undergoing joint replacement surgeries (Goesling et
al., 2016). The percentage of opioid naïve patients continuing to use opioids more than 90 days
across diverse procedures after their procedure indicates that this prolonged use should be
viewed as a surgical complication (Brummett et al., 2017).
Lastly, many studies suggest that postoperative opioid prescribing practices may
contribute to prolonged use. Multiple studies indicate that opioids are overprescribed after
surgery, leading researchers to conclude that this could potentially contribute to misuse and
diversion (Bates et al., 2011; Harris et al., 2014; Harris et al., 2013; Rodgers et al., 2012). Two
studies show wide variation in prescribing practices, even for the same surgery; whether this is
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due to varying patient needs or other provider factors is not clear (Harris et al., 2013; Hill et al.,
2017).
2.4.2.b Certain patient characteristics may be predictive of prolonged postoperative
opioid use.
Patient characteristics may be predictive of prolonged postoperative opioid use, but these
are inconsistently reported across studies. Demographics such as gender, age, race, ethnicity, and
socioeconomic status were particularly inconsistent as predictors. For instance, in one analysis,
patient demographics predicting prolonged postoperative opioid use were significant for those
less than 65 years of age, female gender, household income under $60,000 per year, and private
insurance (Johnson et al., 2016). Conversely, in another database analysis, men and those over
50 years of age had higher rates of prolonged use (Sun et al., 2016). Yet another study found no
difference in opioid use six months after surgery by age, gender, ethnicity, or type of surgery
(Goesling et al., 2016). Rates also varied by geographic location. Statistically significant higher
rates of prolonged postoperative opioid use were found in the U.S. Census Bureau West South
Central (7.02%) and East South Central (7.85%) regions compared to the Middle Atlantic
Region (3.78%) (Brummett et al., 2017).
Researchers consistently found that patients who are currently using opioids,
benzodiazepines, or addicted to alcohol were at increased risk of prolonged postoperative
use (Brummett et al., 2017; Goesling et al., 2016; Johnson et al., 2016; Rozet et al., 2014;
Sun et al., 2016; Waljee et al., 2016). In fact, mental health disorders such as anxiety and
depression, tobacco and alcohol abuse, multiple co-morbidities, and pre-existing pain conditions
were independent predictors of prolonged postoperative opioid use across all surgical procedures
(Brummett et al., 2017; Johnson et al., 2016). Preoperative opioid prescriptions, depressive
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symptoms, and self-perceived risk of addiction were better predictors of prolonged use than
the reported postoperative intensity and duration of pain (Carroll et al., 2012). One study
found that a preoperative opioid prescription greater than 60 morphine milligram equivalents
per day was associated with prolonged use after surgery (Goesling et al., 2016). Additionally,
patients already on opioids preoperatively were often overprescribed opioids postoperatively
(Waljee et al., 2016). Lastly, PTSD and preoperative opioid use were factors leading to chronic
postoperative opioid use in young veterans having minor elective surgeries (Rozet et al., 2014).
2.5 Discussion
Studies included in this integrative review indicate that 4% to 13% of opioid naïve
patients are taking opioid pain relievers three months or more after their procedure, suggesting
that prolonged postoperative opioid use occurs frequently after elective surgery in this population
(Brummett et al., 2017; Carroll et al., 2012; Goesling et al., 2016; Johnson et al., 2016; Sun et al.,
2016). It is unclear which surgeries, if any, carry the highest risks for patients. Moreover,
research findings suggest that prolonged opioid use after surgery is related to factors other than
the type and duration of surgical pain (Carroll et al. 2012).
Current evidence suggests that prolonged postoperative opioid use is related to exposure
through prescriptions and to patient characteristics. Across multiple studies, patients who were
already using opioids, benzodiazepines, antidepressants, anxiolytics, tobacco, or abusing alcohol
were at higher risk for prolonged postoperative opioid use (Brummett et al., 2017; Goesling et
al., 2016; Johnson et al., 2016; Rozet et al., 2014; Sun et al., 2016; Waljee et al., 2016).
Mental health disorders, depressive symptoms, a self-perceived risk of addiction, and multiple
co-morbidities also independently predicted prolonged use (Brummett et al., 2017; Carroll et al.,
2012; Johnson et al., 2016). The contribution of patient demographics is unclear. Further
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evidence is needed to ascertain the contribution of patient characteristics to prolonged
postoperative opioid use.
Large prospective studies are needed to determine which surgeries place patients at an
increased risk for prolonged opioid use, how prescribing practices affect prolonged use, and
which patient factors contribute to prolonged use. Notably, there are inconsistencies among
researchers as to the definitions of “prolonged opioid use” and “opioid naïve.” Standard
definitions would provide consistency and allow comparison of results across studies. Ultimately
these studies will lead to evidenced based prescribing practice guidelines and improved
perioperative pain management.
2.6 Implications for Nursing
Based on current evidence, two million patients undergoing elective surgeries each year
will use opioid analgesics more than 90 days after their procedure (Brummett et al., 2017). It is
imperative that nurses and other clinicians appropriately manage surgical patients preoperatively,
intraoperatively, at discharge, and throughout the recovery period in order to prevent prolonged
use of these medications. Nurses need to screen opioid naïve patients preoperatively using the
factors we have uncovered placing them at higher risk for prolonged postoperative opioids use:
patients currently taking, benzodiazepines, antidepressants, anxiolytics, tobacco, or abusing
alcohol, as well as those patients with mental health disorders, depressive symptoms, a selfperceived risk of addiction, and multiple co-morbidities. Nurses also need to educate patients on
postoperative pain control expectations, expected time to recovery, and follow the patients
closely after discharge. The wide variations in prescriber practices, the large percentage of
unused opioids, and the increase in potency of opioids prescribed highlights the need for
postoperative prescribing guidelines (Bates et al., 2011; Harris et al., 2014; Hill et al., 2017; Kim

42

et al., 2016; Rodgers et al., 2012; Wunsch et al., 2016). Nurses can counsel patients on
appropriate use and disposal of opioids, non-narcotic pain relievers, and non-traditional pain
control techniques. Additionally, acute pain should be managed through multi-modal pain relief
techniques including perioperative anesthetics that are opioid sparing.
Both qualitative and quantitative studies are needed for a better understanding of factors
related to prolonged postoperative opioid use, the type of surgeries that place patients at most
risk, and the effect postoperative exposure to opioids has on prolonged use. This will facilitate
development of patient focused interventions including screening tools to identify high risk
patients, pain management protocols and prescribing guidelines, and educational strategies for
patients, clinicians, and stakeholders. Nurses are poised to develop and refine evidenced based
tools that will inform best practices for acute postoperative pain management.
2.7 Limitations
There are several limitations to this integrative review. First, there is a relatively small
body of research related to this topic and some of the studies were by the same author group,
indicating a need to replicate the research in other samples. There are also a variety of
methodological limitations to the studies analyzed. There are no randomized controlled trials and
there were no qualitative analyses. Some studies relied on self-reports from patients and may
therefore be biased by inaccurate recall or an unwillingness to be forthcoming about the
medications used, especially if they are supplementing with illicit drugs. Several studies relied
on insurance database information that may be incomplete or inaccurate. Additionally, the
database reviews may not be reflective of the general population as those with Medicare and
Medicaid, and the uninsured were not represented. Some of the databases were geographically
limited.
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In addition to methodological limitations, opioid naïve was defined differently by
different authors. Furthermore, alternative methods for pain control, such as multi-modal
analgesia techniques that augment the efficaciousness of opioids, were not discussed. The
possibility of illicit drug use in patients was not investigated in these studies and should be
included if possible in future research.
2.8 Conclusions
This integrative review includes a synthesis of the association between postoperative
exposure to opioids and specific patient characteristics associated with prolonged postoperative
opioid use. Findings from this review identify gaps in our current knowledge and support the
need for future research. This review indicates that prolonged postoperative opioid use is
common after surgical procedures and is related to postoperative opioid exposure and patient
factors rather than the duration and intensity of post-surgical pain. Characteristics putting
patients at higher risk were mental health disorders, multiple co-morbid conditions, and the
preoperative use of opioids, benzodiazepines, antidepressants, anxiolytics, as well as tobacco or
alcohol abuse. The contribution of patient demographics is unclear as is the type of surgery,
whether major or minor. Further research describing the effects of postoperative opioid exposure
on prolonged opioid use, postoperative opioid prescribing practices, and the identification of
potential predictive characteristics of prolonged postoperative opioid use. It is crucial for
advanced practice clinicians, surgeons, nurses, and other healthcare professionals to better
understand which patient populations are at an increased risk and preemptively prevent misuse
from occurring.
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Table 1
Electronic Database Search Strategies
Electronic Database

Search Strategy

CINAHL

(MH "Postoperative Pain" OR MH "Patient-Controlled Analgesia" OR TI
post* N4 pain* OR AB post* N4 pain* OR TI patient-controlled N4
analgesi* OR AB patient-controlled N4 analgesi*) AND (MH "Prescribing
Patterns" OR MH "Inappropriate Prescribing" OR MH "Prescriptions,
Drug" OR MH "Self Administration+" OR MH "Self Medication" OR TI
prescrib* N4 practice OR AB prescrib* N4 practice) Limits: 2011/01/01 to
2017/06/21; United States

Cochrane Database of Systematic
Reviews

((opioid or opiate or opioid-naive) OR ("substance use disorder" or "drug
abuse")) AND (postsurgical or postoperative) AND ("prescribing practice"
or prescribe or prescription)

Cochrane Central Register of
Controlled Trials

((opioid or opiate or opioid-naive) OR ("substance use disorder" or "drug
abuse")) AND (postsurgical or postoperative) AND ("prescribing practice"
or prescribe or prescription)

EMBASE

(‘Opiate’/mj OR ‘prescription’/mj OR ‘prescription opioids’:ab,ti OR
‘inappropriate prescribing’/mj OR ‘potentially inappropriate
medication’/mj OR ‘drug abuse’/mj OR ‘opioid-naïve patients’:ab,ti) AND
(‘surgical patient’/mj OR ‘postoperative pain’/mj OR ‘postoperative
complication’/mj OR ‘postoperative care’/mj OR ‘prolonged opioid
use’:ab,ti) AND ([young adult]/lim OR [adult]/lim OR [middle aged]/lim
OR [aged]/lim OR [very elderly]/lim) AND [english]/lim

PubMed

(("Practice Patterns, Physicians'”[Mesh] OR prescribing pattern*[tiab] OR
"Drug Administration Schedule"[Mesh] OR “Analgesics, Opioid”[Mesh]
OR “opioid use”[tiab] OR “opioid-naive patients”[tiab]) AND (“surgery
procedures”[tiab] OR surgery[tiab]) AND ("Pain, Postoperative"[Mesh]
OR “postoperative period”[tiab] OR “postoperative pain”[tiab])) AND
"united states"

ClinicalTrials.gov

postoperative opioid prescription Limits: Adults; United States

Annual Meeting of the American
Pain Society

postoperative opioid
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Authors (year)
Bates et al. (2011)

Objective
To determine if urologists are
overprescribing opioids after
surgery

Method
Patient surveys

Sample
275 patients undergoing
urology surgery

Results
Over 40% of prescribed opioids
were not used and 67% of patients
had leftover pain medication.
Opioids are overprescribed after
surgery.

Brummet et al. (2017)

To determine incidence of
prolonged postoperative opioid
use in opioid naïve patients
after major and minor surgeries

Retrospective
database analysis

36,177 patients from a
managed care insurance
affiliated with
OptumInsight from
Clinformatics Data Mart
who underwent 13
common surgical
procedures

5.9% to 6.5% of opioid naïve
patients continued to use opioids >
90 days post-surgery whether the
procedure was major or minor,
suggesting factors other than pain
contribute to long term use.

Carroll et al. (2012)

To determine if psychological
distress and substance abuse are
predictors of prolonged
postoperative opioid use (pilot
study)

Prospective,
longitudinal
observational study

109 patients undergoing
mastectomy,
lumpectomy,
thoracotomy, total knee
replacement, or total hip
replacement

6% of patients continued on opioids
> 150 days post-surgery. Predictors
were preoperative opioid use,
depression, and self-reported
perceived risk of addiction.

Goesling et al. (2016)

To determine patient risk
factors for chronic post-op
opioid use, the effect of pain
scores preoperatively and at 6
months after TKA and THA on
opioid use, and to explore the
natural course of opioid use in
these surgical patients

Secondary analysis
of data from a
prospective outcome
study that used
telephone and mail
surveys

574 patients who had
TKA or THA

8.2 % of opioid naïve TKA and
4.3% of opioid naïve THA patients
continued on opioids 180 days-postsurgery. Pre-op opioid dose >
60MME was independently
associated with chronic opioid use,
and there was no association found
between change in joint pain over
time and chronic opioid use.

Harris et al. (2013)

To understand (1) postoperative
opioid prescribing by
dermatologists, (2) the amount
of postoperative pain

Prospective
observational study
utilizing telephone
follow up

212 patients undergoing
single skin excision
surgical procedures

34% of patients received a
postoperative opioid prescription.
86% of patients who filled a
prescription had leftover pills and

medications actually used, and
(3) patient and surgical factors
associated with amount used

53% planned to store them for
future use. Female, younger age,
and surgery type were predictors of
increased opioid use
postoperatively, but the overall fit of
the model was limited. Surgery with
graft closures was the only surgical
characteristic indicative of increased
pain. Opioids are overprescribed
after surgery.
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Harris et al.
(2014)

To understand postoperative
opioid prescribing practices

Retrospective chart
review and email
survey to
dermatologists

233 patients who had
undergone single skin
excision surgical
procedures and an email
survey of 556 members
of the American Society
for Dermatological
Surgery

There is wide variation in
prescribing practices among
dermatologists nationally and within
the same institution. Opioids are
overprescribed after surgery.

Hill et al. (2017)

To (1) examine opioid
prescribing practices after
general surgery and (2)
determine the number of pills
that should be prescribed

EMR chart review
& patient survey

642 patients undergoing
partial mastectomy,
partial mastectomy with
sentinel lymph node
biopsy, laparoscopic
cholecystectomy,
laparoscopic inguinal
hernia repair, and open
inguinal hernia repair

72% of prescribed opioids were not
used and there was a wide variety of
prescribing practices among
prescribers at same facility. Opioids
are overprescribed after surgery.

Johnson et al. (2016)

To evaluate opioid use in
opioid naïve patients after
common hand surgeries

Retrospective
insurance database
analysis

59,735 patients from the
Thomson Reuters
Truven MarketScan
Commercial Claims
Database

13% of opioid naïve patients
continued to fill opioid prescriptions
greater than 90 days post-surgery.

Kim et al. (2016)

To evaluate opioid usage after
outpatient upper extremity
surgery

Prospective
observational study

1,416 patients who had
outpatient upper
extremity surgery

66% of prescribed opioids were not
used; opioids are overprescribed
after surgery which could lead to
misuse and diversion. Procedure

type and location, patient age, and
type of insurance determined
increased postoperative opioid
consumption.
To determine the amount of
unused opioids after outpatient
upper extremity surgery

Patient survey

250 outpatients who had
upper extremity surgery

77% of patients took less than half
of their prescribed opioids. The
number of opioids used differed by
insurance type.

Rozet et al. (2014)

To determine patient risk
factors for chronic
postoperative pain

Single center
retrospective study

145 young veterans (age
18-50) having minor
elective surgeries

Patients with PTSD are at higher
risk for prolonged post-op opioid
use. Preoperative opioid use is the
primary risk factor for chronic pain
post-surgery.

Sun et al. (2016)

To compare opioid naïve
patients undergoing eleven
types of surgery with
nonsurgical patients to examine
the relative risk of prolonged
opioid use

Retrospective
insurance database
analysis

641,941 opioid naïve
surgical patients and
18,011,137 opioid naïve
non-surgical patients
from the Thomson
Reuters Truven
MarketScan Commercial
Claims Database

Increased rate of chronic opioid use
in patients undergoing TKA, THA,
open and laparoscopic
cholecystectomy, open and
laparoscopic appendectomy, simple
mastectomy, FESS, and cesarean
delivery. Patient factors contributing
to prolonged opioid use were
preoperative use of
benzodiazepines, antidepressants,
and history of drug abuse.

Waljee et al. (2016)

To evaluate opioid use after
four common hand surgery
procedures

Retrospective
insurance database
analysis

296,452 patients from
the Thomson Reuters
Truven MarketScan
Commercial Claims
Database

4.5% of patients received an opioid
refill after minor hand surgery.
Factors associated with refills were
age, type of insurance, type of
surgery, and preoperative opioid
use.

Wunsch et al. (2016)

To examine trends in
prescribing practices over time
for opioid naïve patients
undergoing four low risk
surgeries. Time points

Retrospective
insurance database
analysis

155,297 opioid naïve
patients from the
Clinformatics Data Mart
Database undergoing

The proportions of patients filling
prescriptions for any opioid
increased over time and the mean
morphine equivalents prescribed
increased over time.
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Rodgers et al. (2012)

examined were 2004, 2008,
2012

low risk surgical
procedures

Note: TKA = total knee arthroplasty; THA = total hip arthroplasty; MME = morphine milligram equivalent dose; EMR = electronic
medical record; PTSD = post-traumatic stress disorder; FESS = functional endoscopic sinus surgery
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Table 3
Quality Assessment of Included Articles

54

Bates et al. (2011)
Brummet et al. (2017)
Carroll et al. (2012)
Goesling et al. (2016)
Harris et al. (2013)
Harris et al. (2014)
Hill et al. (2017)
Johnson et al. (2016)
Kim et al. (2016)
Rodgers et al. (2012)
Rozet et al. (2014)
Sun et al. (2016)
Waljee et al. (2015)
Wunsch et al. (2016)

Research
questions/
objectives/
hypotheses
clear and
appropriate
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Clear overview of
intervention with
use of appropriate
outcome measures
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Sample
size given

Attrition
rate/missing
data discussed

Data analysis
adequately
described and
rigorous

Outcomes
clearly
described

Ethical issues
are suitably
addressed

Total
Score

1
1
1
1
1
1
1
1
1
1
1
1
1
1

1
1
0
1
0
1
1
1
0
1
0
0
1
0

1
1
1
1
1
1
1
1
1
1
1
1
1
1

1
1
1
1
1
1
1
1
1
1
1
1
1
1

1
1
0
1
1
1
1
1
1
0
1
N/A
0
1

7
7
5
7
6
7
7
7
6
6
6
5
6
6

Note. N/A, not applicable. Criteria adapted from Clark, A. K., Wilder, C. M., & Winstanley, E. L. (2014). A systematic review
of community opioid overdose prevention and naloxone distribution programs. J Addict Med, 8(3), 153-163 and Jinks, A.,
Cotton, A., & Rylance, R. (2011). Obesity interventions for people with a learning disability: an integrative literature review. J
Adv Nurs, 67(3), 460-471.
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